News

Results   11-20 of 20

microEEG® System cleared for commercial distribution

June, 2012

Bio-Signal Group announces that the U.S. Food and Drug Administration has cleared the Company’s microEEG® System for commercial distribution.

The microEEG® System selected for a Moderated Poster Presentation

May, 2012

The microEEG® System diagnostic utility in identifying aberrant electrographic categories in Emergency Department patients with Altered Mental Status, has been selected for a Moderated Poster Presentation at the SAEM 2012 Annual Meeting in Chicago on May 9-12. The abstract has been scheduled for presentation on Saturday, May 12, 1:00 – 2:00 PM.

The microEEG® System selected to represent the best research in the Emergency Medicine field

May, 2012

BSG’s clinical trial results on the use of the microEEG® System in the Emergency Department, has been selected for the Plenary Session at the Society of American Emergency Medicine (SAEM) in Chicago on May 9-12. This work has been selected over 1,100 abstracts to represent the best research in the Emergency Medicine field. The session is scheduled for presentation on Thursday, May 10, 4:30 – 6:00 PM

The microEEG® System is selected to ascertain subclinical seizures/seizure freedom

May, 2012

The microEEG® System is selected to ascertain subclinical seizures/seizure freedom in pediatric patients with cerebral malaria receiving enteral Levetiracetam (LVT). The unique features of the BSG’s system also allows for continuously monitoring 2-3 patients simultaneously in the compact area occupied by the Queen Elizabeth Center Hospital in Malawi. The two year study is funded by NINDS and affiliated with Michigan State University. View More

BSG is awarded best poster abstract

December, 2011

BSG is awarded best poster abstract for originality and relevance for EEG Interpretation Systems and Methods at the American Epilepsy Society conference (AES 2011), (Poster Abstract 3.113, Program Book PDF). The selection was conducted by Dr. Elson So, Professor of Neurology and Chair of Electroencephalography (EEG) at the Mayo Clinic College of Medicine in Rochester, Minnesota. View Poster

iMedicalApps review

October, 2011

iMedicalApps reviews the microEEG® System and calls it ” . . . a truly impressive peripheral device for monitoring EEG data while presenting minimal invasiveness. microEEG® has emerged as the clear leader in terms of wearable EEG Bluetooth amplifier design for the ambulatory and emergency department setting.” View More

510(k) filed for the microEEG® System

September, 2011

BSG files FDA 510(k) Premarket Notification (application) for the microEEG® System.

Evaluation of the microEEG® System

August, 2011

TUV of North America Inc. has completed an evaluation of the microEEG® System to EMC and medical safety requirements and found it to be in compliance. View More

The microEEG® System chosen for an adolescent “frontal asymmetry” study

August, 2011

The microEEG® System has been chosen for an adolescent “frontal asymmetry” study at the University of California-Irvine (UCI). The five year study will employ BSG’s system to acquire two EEGs (twelve months apart) in each of 35 participants per year.

A large scale clinical trial is in progress to determine the benefit of BSG’s microEEG® System in the Emergency Department

May, 2011

A large scale clinical trial is in progress to determine the benefit of BSG’s microEEG® System in the Emergency Department, Diagnostic Utility of Emergency Electroencephalography in Identifying Non-Convulsive Seizures and Subclinical Status Epilepticus in Patients with Altered Mental Status. View More